THE US Food and Drug Administration said it might permit an implantable electrical device for the treatment of epilepsy made by Cyberonics to also be marketed as a therapy for chronic depression that is resistant to other treatments.
The agency set a number of conditions on the tentative approval, and Cyberonics said it hoped to meet them before the end of May.
Cyberonics, based in Houston, said 4.4 million Americans suffer the severe and recurring forms of depression that might be treated with the US$15,000 device.
" If it is adopted for depression at the same rate as it has been for epilepsy, we will pass US$1 billion in sales by 2010," said Robert Cummins, the chairman, chief executive and president of the company.
Some doctors said the market might not be as large as the company estimated because many severely depressed patients do not receive treatment, and others do not complete the courses of drugs and other treatments required before the implant could be considered.
The device, which is called the VNS Pulse 102 and is the size of a pocket watch, is implanted in the upper chest and connected via thin wires to the vagus nerves in the neck.
It sends pulses through the nerves into parts of the brain associated with the diseases being treated.
What is MICR Check Printing
This article will cover the history of the MICR line and the MICR technology associated with how the signal is read and understood, including a glossary of all terms used in the MICR industry. The article includes: The development of the MICR font MICR Readers MICR Waveform Theory What Affects the MICR Signal Level? More information can be found at: http://www.printerm.com/micrdef.htm
For better immune function
Question : IS there any supplement available in the market to help improve immune function and at the same time fight the damaging effects of free radicals?
Easing menopause naturally
IF MENOPAUSE IS A NATURAL PHASE of womanhood, why not treat the symptoms the natural way? Although some healthcare providers recommend hormone replacement therapy (HRT) as the standard treatment for menopause, there remains much controversy on the advantages and risks associated with the treatment.
